147 related articles for article (PubMed ID: 21464784)
21. [Primary cutaneous anaplastic large cell lymphoma: Report of one case].
Navarrete-Dechent C; Molgó M; Sandoval-Osses M; González S
Rev Med Chil; 2015 Oct; 143(10):1351-5. PubMed ID: 26633281
[TBL] [Abstract][Full Text] [Related]
22. Primary Cutaneous CD30+ Lymphoproliferative Disorders in a Patient with Severe Atopic Dermatitis: Is There a Causative Link?
Zychowska M; Woźniak Z; Maj J
Acta Derm Venereol; 2018 Jan; 98(1):123-125. PubMed ID: 28952656
[No Abstract] [Full Text] [Related]
23. CD30-rich transformed mycosis fungoides or anaplastic large cell lymphoma? How to get it right.
Kadin ME
Br J Dermatol; 2015 Jun; 172(6):1478-1479. PubMed ID: 26036155
[No Abstract] [Full Text] [Related]
24. The importance of accurately characterizing lymphoproliferative disease.
Foss FM
Oncology (Williston Park); 2009 Nov; 23(13):1168, 1170. PubMed ID: 20043467
[No Abstract] [Full Text] [Related]
25. Methotrexate-associated lymphoproliferative disorder presenting as primary cutaneous anaplastic large cell lymphoma with generalized skin lesions.
Masuda Y; Imura K; Sano Y; Yagi H
J Dermatol; 2024 Feb; 51(2):e53-e54. PubMed ID: 37752863
[No Abstract] [Full Text] [Related]
26. Molluscum contagiosum infection with features of primary cutaneous anaplastic large cell lymphoma.
Shalabi D; Ringe J; Lee JB; Nikbakht N
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045148
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous CD30+ T-cell lymphoproliferative disorder presenting as paraphimosis: a case report and review of the literature.
McNab PM; Jukic DM; Mills O; Browarsky I
Dermatol Online J; 2011 Jul; 17(7):3. PubMed ID: 21810388
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous anaplastic large cell lymphoma successfully treated with low-dose oral methotrexate.
Fujita H; Nagatani T; Miyazawa M; Wada H; Koiwa K; Komatsu H; Ikezawa Z
Eur J Dermatol; 2008; 18(3):360-1. PubMed ID: 18474486
[No Abstract] [Full Text] [Related]
29. Efficacy of Vinblastine in Primary Cutaneous Anaplastic Large Cell Lymphoma.
Laly P; Ingen-Housz-Oro S; Beylot-Barry M; Verneuil L; Adamski H; Brice P; Bagot M
JAMA Dermatol; 2015 Sep; 151(9):1030-1. PubMed ID: 26108120
[No Abstract] [Full Text] [Related]
30. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
31. Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young.
Papalas JA; Van Mater D; Wang E
Am J Dermatopathol; 2010 Dec; 32(8):821-7. PubMed ID: 20881832
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous anaplastic large cell lymphoma of the medial canthus and orbit.
Koreen IV; Cho RI; Frueh BR; Elner VM
Ophthalmic Plast Reconstr Surg; 2009; 25(1):63-5. PubMed ID: 19273934
[TBL] [Abstract][Full Text] [Related]
33. A rare and isolated presentation of primary cutaneous anaplastic large cell lymphoma.
Shah M; Pawar M; Zawar V
Acta Dermatovenerol Alp Pannonica Adriat; 2018 Mar; 27(1):33-34. PubMed ID: 29589643
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases.
Kong YY; Dai B; Kong JC; Lu HF; Shi DR
Histopathology; 2009 Aug; 55(2):189-96. PubMed ID: 19694826
[TBL] [Abstract][Full Text] [Related]
35. Primary cutaneous extranodal marginal zone B-cell lymphoma of the eyelid skin: Diagnostic clues and distinction from other ocular adnexal diseases.
Stagner AM; Jakobiec FA; Freitag SK
Surv Ophthalmol; 2016; 61(3):333-8. PubMed ID: 26545575
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous anaplastic large cell lymphoma in a child simulating primary cutaneous Hodgkin's disease.
Mahajan VK; Jindal R
Indian J Dermatol Venereol Leprol; 2016; 82(1):98-101. PubMed ID: 26728828
[No Abstract] [Full Text] [Related]
37. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
[TBL] [Abstract][Full Text] [Related]
38. Practical Management of CD30⁺ Lymphoproliferative Disorders.
Hughey LC
Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma--is it a new variant?
Kumaran MS; Jithendriya M; Nagaraj P; Tirumalae R; Jayaseelan E
Indian J Dermatol Venereol Leprol; 2012; 78(3):354-7. PubMed ID: 22565437
[TBL] [Abstract][Full Text] [Related]
40. Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders.
Ferrara G; Ena L; Cota C; Cerroni L
Am J Surg Pathol; 2015 Nov; 39(11):1511-7. PubMed ID: 26371781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
